New injection aims to tame 'Silent' high uric acid
NCT ID NCT06859073
First seen Oct 31, 2025 · Last updated Apr 25, 2026 · Updated 26 times
Summary
This early-stage study tests an experimental drug called NNC4004-0002 in 60 adults with high uric acid but no symptoms. The main goal is to check if a single injection under the skin is safe and well-tolerated. Researchers will also measure how well it lowers uric acid levels. Participants will be randomly assigned to receive the drug or a placebo (saline) and will be followed for about 7 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PAREXEL Glendale/LA EPCU
NOT_YET_RECRUITINGGlendale, California, 91206, United States
-
PAREXEL Intl - EPCU-Baltimore
RECRUITINGBaltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.